 |
Pharmaceutical Industry:
Organizational
Transformation
|
|
| | Client: |
| A
major global pharmaceutical manufacturer with a strong biopharmaceutical presence.
|
| | Problem: | | U.S.
biopharmaceutical division plagued by supply issues, process inefficiencies (including
declining yield) and low morale. There was corporate concern regarding division's
ability to meet production needs to support launch of new 'blockbuster' product.
|
| | Approach: | | A
broad assessment was conducted to evaluate organizational structure, behaviors,
leadership and management systems, manufacturing process capabilities and quality
systems. The assessment led to the implementation of a comprehensive operational
improvement program employing integrated Six-Sigma/SPC and OD approaches focused
on improving the technical, compliance, and personal skills performance of organization.
|
| | Results:
| | An
effective transformation of the division was achieved within 9 months, including:
Doubling of production capacity
10% - 20% increase in production efficiency (yield)
50% reduction in batch record review cycle time
$2M in specific cost savings
Higher production reliability/product consistency
Improved management & control of operations through the introduction
of a multi-level metrics (monitoring) program
Improved management & staff competency to support sustained
performance and launch of new blockbuster product
Improved morale
Successful pAI for new blockbuster product
10-Fold ROI for client
|
| | | |
|